Monday, 23 December 2019

FDA approves Intra Cellullar's schizophrenia treatment

The U.S. Food and Drug Administration has approved Intra-Cellular Therapies Inc's investigational drug to treat schizophrenia, the company said on Monday.


from Reuters: Health News https://ift.tt/2EY3Q7X

No comments:

Post a Comment